industry influence

The Physicians Committee

industry influence

Prevention Over Pharmaceuticals

The pressure is on in the pharmaceutical world, after Eli Lilly announced that its new cholesterol-lowering drug failed to prevent heart disease. The drug—which was pulled from clinical trials in October—had looked promising: It lowered patients’ LDL (“bad”) cholesterol levels, while boosting their HDL (“good”) cholesterol numbers. But as the trial went on, patients continued to suffer from heart attacks at the same rate as a placebo group.

The Physicians Committee Sues USDA and DHHS, Exposing Industry Corruption in Dietary Guidelines Decision on Cholesterol

According to previously unreleased documents obtained by the Physicians Committee under the Freedom of Information Act, the American Egg Board had directly nominated one individual who was then placed on the DGAC. A second member was actively receiving egg-industry research grants according to industry documents, and two others worked at a university that had requested and received more than $100,000 from the American Egg Board for research aimed at challenging the cholesterol limits.

‘Cholesterol Kills’: Billboards Warn House Ag Committee Chair

WASHINGTON—“Cholesterol kills,” warn billboards near the Texas home offices of Agriculture Committee chairman Rep. K. Michael Conaway. The Physicians Committee—a nonprofit of 12,000 doctors—is appealing to Rep. Conaway with the billboards and a letter after he convened an October congressional hearing over the Agriculture Committee’s “concerns with the process of developing the Dietary Guidelines,” which are poised to remove cholesterol warnings when they are released in December.